Mylan (NSDQ:MYL) said today that it launched a generic version of Baxter‘s (NYSE:BAX) Brevibloc heart drug in the U.S.
The company’s injectable product, esmolol hydrochloride in sodium chloride, will be offered in single-dose plastic bags, according to Mylan.
Get the full story at our sister site, Drug Delivery Business News.
The post Mylan launches generic Brevibloc heart injection appeared first on MassDevice.